Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,833 | 688 | 62.4% |
| Education | $5,717 | 11 | 27.8% |
| Travel and Lodging | $2,019 | 7 | 9.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $6,748 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,364 | 164 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,843 | 88 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,616 | 80 | $0 (2024) |
| Veran Medical Technologies, Inc. | $1,075 | 2 | $0 (2018) |
| Grifols USA, LLC | $669.28 | 38 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $552.47 | 20 | $0 (2024) |
| Mylan Specialty L.P. | $476.52 | 27 | $0 (2024) |
| Philips Electronics North America Corporation | $395.63 | 20 | $0 (2022) |
| Genentech USA, Inc. | $347.90 | 18 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,338 | 84 | INTUITIVE SURGICAL, INC. ($6,748) |
| 2023 | $1,528 | 77 | GlaxoSmithKline, LLC. ($280.71) |
| 2022 | $1,461 | 75 | Boehringer Ingelheim Pharmaceuticals, Inc. ($355.30) |
| 2021 | $1,327 | 76 | AstraZeneca Pharmaceuticals LP ($286.97) |
| 2020 | $1,174 | 68 | GlaxoSmithKline, LLC. ($235.79) |
| 2019 | $1,584 | 99 | GlaxoSmithKline, LLC. ($267.62) |
| 2018 | $3,028 | 111 | Veran Medical Technologies, Inc. ($1,075) |
| 2017 | $2,128 | 116 | GlaxoSmithKline, LLC. ($564.69) |
All Payment Transactions
706 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.97 | General |
| Category: HFCWO | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $10.18 | General |
| Category: HFCWO | ||||||
| 10/25/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $36.61 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.51 | General |
| Category: HFCWO | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $114.35 | General |
| 08/22/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.89 | General |
| Category: HFCWO | ||||||
| 08/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $35.32 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 858 | 1,037 | $287,750 | $69,344 |
| 2022 | 15 | 722 | 910 | $308,387 | $70,160 |
| 2021 | 15 | 600 | 790 | $308,887 | $76,817 |
| 2020 | 14 | 528 | 713 | $249,023 | $62,579 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 237 | $91,704 | $22,256 | 24.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 30 | 56 | $38,670 | $9,226 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $28,703 | $7,064 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 97 | $26,535 | $6,213 | 23.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 49 | 54 | $18,135 | $5,052 | 27.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 106 | 107 | $18,304 | $4,665 | 25.5% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 95 | 103 | $11,963 | $3,055 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 21 | $11,354 | $2,845 | 25.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 110 | 134 | $12,052 | $2,650 | 22.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 63 | 71 | $7,241 | $1,696 | 23.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 22 | $5,646 | $1,133 | 20.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 14 | 14 | $8,586 | $1,131 | 13.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 17 | $3,710 | $1,057 | 28.5% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 32 | 33 | $3,373 | $875.03 | 25.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 14 | 14 | $1,774 | $427.28 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 147 | 215 | $84,124 | $20,614 | 24.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 46 | 104 | $83,720 | $17,830 | 21.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 69 | $20,769 | $5,562 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $20,741 | $5,190 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 61 | $16,836 | $3,657 | 21.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 137 | 159 | $17,490 | $3,316 | 19.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 39 | 47 | $10,716 | $2,652 | 24.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 56 | 57 | $9,234 | $2,619 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 17 | $9,299 | $2,306 | 24.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $6,468 | $1,581 | 24.4% |
About Dr. Eduardo Egea, M.D
Dr. Eduardo Egea, M.D is a Internal Medicine healthcare provider based in Alpharetta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2010. The National Provider Identifier (NPI) number assigned to this provider is 1346567914.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eduardo Egea, M.D has received a total of $20,569 in payments from pharmaceutical and medical device companies, with $8,338 received in 2024. These payments were reported across 706 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($12,833).
As a Medicare-enrolled provider, Egea has provided services to 2,708 Medicare beneficiaries, totaling 3,450 services with total Medicare billing of $278,900. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Alpharetta, GA
- Active Since 04/22/2010
- Last Updated 04/26/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346567914
Products in Payments
- Da Vinci Surgical System (Device) $6,748
- Spin (Device) $1,075
- TRELEGY ELLIPTA (Drug) $1,053
- OFEV (Drug) $982.00
- ACTHAR (Biological) $719.18
- TEZSPIRE (Biological) $607.93
- NUCALA (Biological) $564.23
- DUPIXENT (Biological) $511.59
- FASENRA (Drug) $455.09
- STIOLTO RESPIMAT (Drug) $430.34
- Prolastin-C (Biological) $399.13
- GLASSIA (Biological) $382.52
- SMARTVEST (Device) $341.22
- Yupelri (Drug) $315.02
- ORENITRAM (Drug) $301.43
- Esbriet (Biological) $283.27
- Prolastin-C Liquid (Biological) $270.15
- Arikayce (Drug) $262.75
- SYMBICORT (Drug) $249.19
- BREZTRI (Drug) $248.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Alpharetta
Dr. Eduard Fatakhov, M.d, M.D
Internal Medicine — Payments: $325,178
Raphael Lopez, Md, MD
Internal Medicine — Payments: $11,613
Jeff Ye, M.d, M.D
Internal Medicine — Payments: $8,929
Ulrike Korte, M.d, M.D
Internal Medicine — Payments: $7,634
Rabahuddin Syed, M.d, M.D
Internal Medicine — Payments: $7,193
Dr. Ji Yeon Lee, Md, MD
Internal Medicine — Payments: $7,027